<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-29</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-29</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>88</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡ç³»ç»Ÿæ­ç¤ºä¸‰çº§æ·‹å·´ç»“æ„åœ¨èƒƒç™Œå…ç–«å¾®ç¯å¢ƒä¸­çš„å…³é”®ä½œç”¨ï¼Œå¹¶å¼€å‘åˆ›æ–°å·¥å…·é¢„æµ‹å…ç–«æ²»ç–—ååº”ã€‚Natureå‘ç°PD-1ä¸ä»…æŠ‘åˆ¶Tç»†èƒæŠ—ç™Œæ´»æ€§ï¼Œè¿˜ä¿æŠ¤å…¶å…äºè€—ç«­ï¼Œæç¤ºå…ç–«æ²»ç–—éœ€å¹³è¡¡ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè°ƒæ§</strong>ï¼šè¯†åˆ«HLA-DR+è‚¿ç˜¤ç»†èƒã€MARCO+å·¨å™¬ç»†èƒã€PLAUR+ä¸­æ€§ç²’ç»†èƒã€è¡°è€CD8+Tç»†èƒã€æˆçº¤ç»´ç»†èƒï¼ˆMMP11+ï¼‰ç­‰å…³é”®ç»†èƒç±»å‹åŠå…¶å¯¹å…ç–«æ²»ç–—çš„å½±å“ï¼Œå¹¶æ¢ç´¢é˜»æ–­MARCOã€PLAURæˆ–è°ƒæ§è¡°è€ç»†èƒçš„ç­–ç•¥ã€‚<br />
*   <strong>ä»£è°¢ä¸å…ç–«</strong>ï¼šå·¨å™¬ç»†èƒèƒè‘¬é©±åŠ¨å¤šèƒºä»£è°¢å¢å¼ºç™Œå¹²ç»†èƒå¯Œé›†åŠè€è¯ï¼›è°ƒæ§ä»£è°¢é€”å¾„ï¼ˆå¦‚ä¹™é†‡é…¸ä»£è°¢ï¼‰ä»¥è°ƒåŠ¨å›ºæœ‰å…ç–«åŠ›æŠ—è‚¿ç˜¤ã€‚<br />
*   <strong>è‚¿ç˜¤ç»†èƒä¸å®¿ä¸»äº’ä½œ</strong>ï¼šæ­ç¤ºç¥ç»å…ƒ-ç™Œç»†èƒå‡æ€§çªè§¦å¢å¼ºèƒ°è…ºç™Œç¥ç»æµ¸æ¶¦ï¼›DMFé‡Šæ”¾mtDNAæ¿€æ´»cGAS-STINGé€šè·¯å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šå•ç»†èƒRNAæµ‹åºã€ç©ºé—´è½¬å½•ç»„å­¦ã€ä½“ç»†èƒè¡¨çªå˜å…‹éš†è¿½è¸ªç­‰æŠ€æœ¯åœ¨è‚¿ç˜¤å…ç–«ã€è¡°è€ã€ç–¾ç—…æœºåˆ¶ç ”ç©¶ä¸­çš„å¹¿æ³›åº”ç”¨ã€‚<br />
*   <strong>ç”Ÿç‰©ä¿¡æ¯å­¦å·¥å…·å¼€å‘</strong>ï¼šå¼€å‘é¢„æµ‹å…ç–«æ²»ç–—ååº”çš„æ–°å·¥å…·ï¼›Kraken2å®ç°å¿«é€Ÿå¾®ç”Ÿç‰©ç»„åˆ†ç±»ã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
MHC II-restricted neoantigenç–«è‹—æœ‰æ•ˆé€†è½¬å†·è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒï¼Œå…‹æœå…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚è€è¯æ€§ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚¿ç˜¤å…ç–«æ²»ç–—ï¼šé€šè¿‡ç–«è‹—æˆ–è¯ç‰©ï¼ˆå¦‚DOT1LæŠ‘åˆ¶å‰‚ï¼‰é‡å¡‘è‚¿ç˜¤å¾®ç¯å¢ƒï¼Œæ¿€æ´»å…ç–«ååº”ã€‚<br />
- ä»£è°¢ä¸å…ç–«ï¼šç ”ç©¶é¤åä»£è°¢å˜åŒ–å¯¹Tç»†èƒå…ç–«çš„æŒä¹…å½±å“ï¼Œä»¥åŠL-è‹¯ä¸™æ°¨é…¸åœ¨Th2ç»†èƒä»£è°¢è°ƒæ§ä¸­çš„ä½œç”¨ã€‚<br />
- ç–¾ç—…æœºåˆ¶ç ”ç©¶ï¼šè§£æNFATc1/c2åœ¨å„¿ç«¥T-ALLç³–çš®è´¨æ¿€ç´ æŠµæŠ—ä¸­çš„ä½œç”¨ï¼›æ¢ç´¢m6Aç”²åŸºåŒ–ã€BRCA1çªå˜ã€C-Cè¶‹åŒ–å› å­å—ä½“4åŸºå› ç¼ºå¤±åŠRIG-Iæ¿€æ´»åœ¨ä¸åŒç–¾ç—…ä¸­çš„ä½œç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æ•´åˆå¤šç»„å­¦åˆ†æï¼ˆATAC-seq, RNA-seq, m6Aæµ‹åº, å…¨åŸºå› ç»„æµ‹åºï¼‰æ­ç¤ºåŸºå› è°ƒæ§å’Œè¡¨è§‚é—ä¼ æœºåˆ¶ã€‚<br />
- åˆ©ç”¨æ•°å­—å­ªç”ŸæŠ€æœ¯è¿›è¡Œä½“å†…ä»£è°¢é€šé‡ä¼°ç®—ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
*   æ™šæœŸå®«é¢ˆç™Œä¸€çº¿æ²»ç–—ä¸­ï¼Œé™çº§åŒ–ç–—è”åˆå®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—å±•ç°å‡ºæ²»ç–—æ½œåŠ›ã€‚<br />
*   é¦–æ¬¡æ„å»ºçš„CIC::DUX4è‚‰ç˜¤ï¼ˆCDSï¼‰è¯±å¯¼æ¨¡å‹imChCDSï¼Œæ­ç¤ºäº†ç™ŒåŸºå› ä»‹å¯¼çš„MHCIä¾èµ–å…ç–«é€ƒè„±æœºåˆ¶ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
-   æ¢ç´¢æ™šæœŸå®«é¢ˆç™Œæ‚£è€…ä¸€çº¿é™çº§åŒ–ç–—è”åˆå®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—çš„ç–—æ•ˆåŠåˆ†å­å…ç–«ç›¸å…³æ€§ã€‚<br />
-   æ„å»ºå¹¶éªŒè¯CIC::DUX4è‚‰ç˜¤ï¼ˆCDSï¼‰è¯±å¯¼å°é¼ æ¨¡å‹ï¼Œç ”ç©¶å…¶è‚¿ç˜¤å‘ç”Ÿæœºåˆ¶åŠå…ç–«é€ƒé€¸é€”å¾„ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
-   å¼€å‘äº†é¦–ä¸ªå¯è¯±å¯¼çš„CIC::DUX4è‚‰ç˜¤ï¼ˆCDSï¼‰å°é¼ æ¨¡å‹ï¼ˆimChCDSï¼‰ï¼Œå¿ å®é‡ç°äº†äººç±»CDSçš„ç‰¹å¾ã€‚<br />
-   ç ”ç©¶äº†é™çº§åŒ–ç–—è”åˆå®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—åœ¨PD-L1é˜³æ€§æ™šæœŸå®«é¢ˆç™Œæ‚£è€…ä¸­çš„ä¸€çº¿æ²»ç–—æ•ˆæœã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç ”ç©¶å‘ç°ï¼Œé™ä½é¥®ç”¨æ°´ç ·å«é‡å¯æ˜¾è‘—é™ä½ç™Œç—‡å’Œå¿ƒè„ç—…æ­»äº¡ç‡ï¼›æ–°å‹â€œçº³ç±³èŠ±â€è¶…è½½å¹²ç»†èƒï¼Œæœ‰æœ›ä¸ºè¡°è€ç»†èƒâ€œå……ç”µâ€ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   ç¯å¢ƒå¥åº·ï¼šé€šè¿‡æ”¹å–„é¥®ç”¨æ°´è´¨é‡ï¼Œé™ä½æ…¢æ€§ç—…æ­»äº¡ç‡ã€‚<br />
*   ç¥ç»é€€è¡Œæ€§ç–¾ç—…ï¼šæ¢ç´¢ä½“å†…å¤©ç„¶åˆ†å­ï¼ˆå¦‚ç²¾èƒºï¼‰åœ¨å¯¹æŠ—é˜¿å°”èŒ¨æµ·é»˜ç—…å’Œå¸•é‡‘æ£®ç—…ä¸­çš„ä½œç”¨ã€‚<br />
*   å†ç”ŸåŒ»å­¦ï¼šåˆ©ç”¨çº³ç±³æŠ€æœ¯å¢å¼ºå¹²ç»†èƒåŠŸèƒ½ï¼Œç”¨äºä¿®å¤è¡°è€ç»†èƒã€‚<br />
*   ç¯å¢ƒæ¯’ç´ æ¸…é™¤ï¼šå¼€å‘ç”Ÿç‰©å·¥å…·ï¼ˆå¦‚å…‰åˆç»†èŒï¼‰ä»¥åº”å¯¹æŒä¹…æ€§åŒ–å­¦æ±¡æŸ“ç‰©ï¼ˆPFASï¼‰ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   åˆ©ç”¨â€œçº³ç±³èŠ±â€é¢—ç²’æ˜¾è‘—æé«˜å¹²ç»†èƒçº¿ç²’ä½“äº§é‡ï¼Œå®ç°èƒ½é‡è½¬ç§»ã€‚<br />
*   å‘ç°å¹¶åˆ©ç”¨å…‰åˆç»†èŒå¸æ”¶é™è§£æŒä¹…æ€§æœ‰æœºæ±¡æŸ“ç‰©ï¼ˆPFASï¼‰çš„èƒ½åŠ›ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (38æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œé€šè¿‡å•ç»†èƒåˆ†æè¯†åˆ«HLA-DR +è‚¿ç˜¤ç»†èƒï¼Œå¹¶åˆ†æå…¶å¯¹ CD8+T ç»†èƒåŠé¢„åçš„å½±å“ï¼Œæ€è·¯æ–°é¢–ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€Tç»†èƒã€å•ç»†èƒã€ç”Ÿä¿¡ã€é€šè·¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=4&amp;sn=05e843389ca7219100c46075fdfa69b0" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>æœ€æ–°14+çƒ­ç‚¹å¥½æ–‡ï¼Œå·¨å™¬ç»†èƒèƒè‘¬é©±åŠ¨å¤šèƒºä»£è°¢å¢å¼ºåŒ–ç–—åç™Œå¹²ç»†èƒå¯Œé›†åŠè€è¯ï¼ç”Ÿä¿¡å‘ç°ç°è±¡ï¼Œå®éªŒè§£é‡Šç°è±¡ï¼Œæ¢ç´¢æœºåˆ¶ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå·¨å™¬ç»†èƒã€ä»£è°¢ã€è€è¯ã€ç”Ÿä¿¡ã€å¯Œé›†<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=1&amp;sn=0d3ec16d44e3b9307b794f06ad777f59" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>è½¬å½•ç»„å­¦çš„ç”Ÿç‰©ä¿¡æ¯å­¦è§†è§’ï¼šæ‰¹é‡ä¸å•ç»†èƒ RNA æµ‹åºåˆ†æçš„å…¨é¢ç»¼è¿°</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šBMELab<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæµ‹åºã€å•ç»†èƒã€è½¬å½•ç»„ã€ç”Ÿç‰©ä¿¡æ¯ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè½¬å½•ç»„å­¦çš„ç”Ÿç‰©ä¿¡æ¯å­¦è§†è§’ï¼šæ‰¹é‡ä¸å•ç»†èƒ RNA æµ‹åºåˆ†æçš„å…¨é¢ç»¼è¿°<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkyNDI1MzE0NA==&amp;mid=2247490208&amp;idx=1&amp;sn=9a13efc0a529369358475cedfc491af7" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œå•ç»†èƒè¯†åˆ«MARCO+å·¨å™¬ç»†èƒæŠ‘åˆ¶CD8Tï¼Œé˜»æ–­MARCOå¢å¼ºå…ç–«æ²»ç–—ç–—æ•ˆã€‚å¹²æ¹¿ç»“åˆç»å…¸é«˜åˆ†æ€è·¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å·¨å™¬ç»†èƒã€å•ç»†èƒã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=7&amp;sn=b3adb73de6de34506a3ace4ee2f920b7" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œå•ç»†èƒè¯†åˆ«PLAUR+ä¸­æ€§ç²’ç»†èƒå¡‘é€ å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒï¼ŒæŠ‘åˆ¶PLAUR å¢å¼ºæŠ— PD1 ç–—æ•ˆã€‚é«˜åˆ†æ–‡ç« ç»å…¸æ€è·¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€å•ç»†èƒã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=5&amp;sn=160e8f43fe8632ef5170207d01963382" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>Redox BiologyåŒåŒºTOPï¼å·¨å™¬ç»†èƒÃ—è¡°è€Ã—èƒè‘¬ä½œç”¨çš„æ–°æœºåˆ¶ï¼Œå€¼å¾—ä¸€å­¦</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šåŒåŒ»æµäº‘Medfocus<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè¡°è€ã€Tç»†èƒã€Bç»†èƒã€å·¨å™¬ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šå—é€šå¤§å­¦å´”å¿—æ˜/é’±æ¹›ç‘’å›¢é˜Ÿè¿‘æœŸåœ¨ã€ŠRedox Biologyã€‹å‘è¡¨ç ”ç©¶ï¼Œé¦–æ¬¡è¯å®ï¼šå·¨å™¬ç»†èƒå› è¿‡åº¦åå™¬é«“é˜ç¢ç‰‡è€Œæå‰è¡°è€ï¼Œæ˜¯è„Šé«“æŸä¼¤åä¿®å¤å—é˜»çš„å…³é”®ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzk3NTY2NDk1Nw==&amp;mid=2247488360&amp;idx=3&amp;sn=8b9207bc1fcd68b884807cf008571108" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>æœ€æ–°14+å¹²æ¹¿ç»“åˆSCIï¼Œä½œè€…é‰´å®šå‡ºå¹²æ‰°ç´ è¯±å¯¼çš„è¡°è€ CD8T ç»†èƒå¹¶æ­ç¤ºå…¶å¯¹å…ç–«æ²»ç–—çš„å½±å“ã€‚è¡°è€è™½è€ï¼Œä½†æ˜¯çœŸçš„ç«ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€è¡°è€ã€Tç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=2&amp;sn=74a9955631053ddce413cf973c99d9e5" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>DMFé‡Šæ”¾mtDNAï¼Œæ¿€æ´»cGAS-STINGé€šè·¯å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šåŒåŒ»æµäº‘Medfocus<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€é€šè·¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæ­ç¤ºâ€œçº¿ç²’ä½“-cGAS-STINGâ€è½´åœ¨DMFæŠ—è‚¿ç˜¤å…ç–«ä¸­çš„æ ¸å¿ƒåœ°ä½ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzk3NTY2NDk1Nw==&amp;mid=2247488360&amp;idx=1&amp;sn=57a879d6fd063e10ae75b53ef6392601" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>é‡ç£…ç ”ç©¶ï¼é¦–æ¬¡ç³»ç»Ÿæ­ç¤ºä¸‰çº§æ·‹å·´ç»“æ„åœ¨èƒƒç™Œå…ç–«å¾®ç¯å¢ƒä¸­çš„å…³é”®ä½œç”¨ï¼Œå¼€å‘åˆ›æ–°å·¥å…·ç²¾å‡†é¢„æµ‹å…ç–«æ²»ç–—ååº”</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šè½¬åŒ–åŒ»å­¦ç½‘<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€æ·‹å·´<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šé€šè¿‡å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„æŠ€æœ¯ï¼Œé¦–æ¬¡ç³»ç»Ÿæ­ç¤ºäº†ä¸‰çº§æ·‹å·´ç»“æ„åœ¨èƒƒç™Œå…ç–«å¾®ç¯å¢ƒä¸­çš„å…³é”®ä½œç”¨ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656511096&amp;idx=1&amp;sn=6098ecb0a0264b1819b6e7a325955ea8" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>ã€è½¬åŒ–åŒ»å­¦ç ”ç©¶ä¸“åœºã€‘å•ç»†èƒæµ‹åºå…¥é—¨å¤§è®²å ‚ï¼šåŠ©æ‚¨é”å®šæ–°é¶ç‚¹ã€ç ´è§£è€è¯æ€§ã€æ­ç¤ºæ¯’æ€§æœºåˆ¶ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼š10x Genomics<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯ã€æµ‹åºã€å•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç›´æ’­æ—¶é—´ï¼š12æœˆ10æ—¥&amp;11æ—¥ï½œä¸‹åˆ 2:00-3:00<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU1MDk1NTY5MA==&amp;mid=2247541029&amp;idx=1&amp;sn=b6f996f0168f755954193d7a79909504" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 28 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (44æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE275681 MHC II é™åˆ¶æ€§æ–°æŠ—åŸç–«è‹—é€†è½¬å…ç–«å¾®ç¯å¢ƒå¹¶å…‹æœå†·è‚¿ç˜¤å¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚çš„è€è¯æ€§ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€vaccineã€MHCã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275681" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE282415 é¤åå…¨èº«ä»£è°¢å˜åŒ–å¯¹ T ç»†èƒå…ç–«äº§ç”ŸæŒä¹…å½±å“ [ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€T cellã€metabolismã€ATAC-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Alok Kumar ; Greg M Delgoffe ; Isha MehtaSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusSystemic nutrient availability waxes and wanes with dietary input. Here we show that short periods of fasting and refeeding have long-lasting effects on T cell immunity. Human or murine T cells from fed hosts have higher metabolic capacity than those from fasted hosts ex vivo and show better/superior metabolic phenotype and immune response/functions in vitro and in vivo settings of virus infection or tumor model. Serum or chylomicrons enriched from lymphatics of fed mice restores the metabolic and immune functions of fasted T cells. Fed T cells had heightened mTORC1-dependent translation of key immunologic and metabolic genes independent of their epigenetic and transcriptional status. mTORC1 inhibition during the fed period mitigates the postprandial benefit of fed T cells over fasted cells. Our data highlight the need to consider diet content and timing as key factors in immune cell analysis, vaccination strategies, and the generation of cellular therapies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282415" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE282410 é¤åå…¨èº«ä»£è°¢å˜åŒ–å¯¹ T ç»†èƒå…ç–«äº§ç”ŸæŒä¹…å½±å“ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€T cellã€metabolismã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Alok Kumar ; Greg M Delgoffe ; Isha MehtaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSystemic nutrient availability waxes and wanes with dietary input. Here we show that short periods of fasting and refeeding have long-lasting effects on T cell immunity. Human or murine T cells from fed hosts have higher metabolic capacity than those from fasted hosts ex vivo and show better/superior metabolic phenotype and immune response/functions in vitro and in vivo settings of virus infection or tumor model. Serum or chylomicrons enriched from lymphatics of fed mice restores the metabolic and immune functions of fasted T cells. Fed T cells had heightened mTORC1-dependent translation of key immunologic and metabolic genes independent of their epigenetic and transcriptional status. mTORC1 inhibition during the fed period mitigates the postprandial benefit of fed T cells over fasted cells. Our data highlight the need to consider diet content and timing as key factors in immune cell analysis, vaccination strategies, and the generation of cellular therapies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282410" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE254001 NFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ§åˆ¶å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by arrayOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254001" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE253999 NFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ¥è°ƒæ§å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Silvia Bresolin ; Valentina SerafinSeries Type : Expression profiling by arrayOrganism : Homo sapienshe glucocorticoid (GC) resistance onset in pediatric T-cell Acute Lymphoblastic Leukemia (T-ALL) patients remains one of the biggest challenges in current cancer treatment. The mechanisms driving this resistance are still not fully understood, making it difficult to predict patient outcomes and to develop effective therapies. Our study uncovered critical insights into the biological processes underlying GC resistance, offering potential breakthroughs for future treatments. Building on our previous research on LCK kinase hyperactivation in GC-resistant T-ALL patients, we have now delved deeper into the LCK downstream NFAT transcription factor family's contribution to GC resistance. We discovered that, even at the time of diagnosis, GC resistant T-ALL patients exhibit an intrinsic low glucocorticoid receptor (GR) activity coupled with high NFATc1 and NFATc2 ones. This dysregulation creates a roadblock to effective GC therapy. Indeed, in the absence of either NFATc1 or NFATc2, the normal transcriptional activity of GR is restored, re-sensitizing the leukemia cells to dexamethasone treatment both in vitro and in vivo. This suggests that NFATc1 and NFATc2 are central to driving GC resistance, as they directly regulate crucial pathways like cholesterol biosynthesis and WNT/Î²-catenin signaling. The identification of NFAT transcription factors as key players in leukemia therapy resistance offers a promising target for future therapeutic strategies, potentially transforming the way we approach treatment for these challenging conditions or autoimmune disorders where glucocorticoids are a cornerstone of treatment.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253999" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE253998 NFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ¥è°ƒæ§å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Silvia Bresolin ; Valentina SerafinSeries Type : Expression profiling by arrayOrganism : Homo sapiensThe glucocorticoid (GC) resistance onset in pediatric T-cell Acute Lymphoblastic Leukemia (T-ALL) patients remains one of the biggest challenges in current cancer treatment. The mechanisms driving this resistance are still not fully understood, making it difficult to predict patient outcomes and to develop effective therapies. Our study uncovered critical insights into the biological processes underlying GC resistance, offering potential breakthroughs for future treatments. Building on our previous research on LCK kinase hyperactivation in GC-resistant T-ALL patients, we have now delved deeper into the LCK downstream NFAT transcription factor family's contribution to GC resistance. We discovered that, even at the time of diagnosis, GC resistant T-ALL patients exhibit an intrinsic low glucocorticoid receptor (GR) activity coupled with high NFATc1 and NFATc2 ones. This dysregulation creates a roadblock to effective GC therapy. Indeed, in the absence of either NFATc1 or NFATc2, the normal transcriptional activity of GR is restored, re-sensitizing the leukemia cells to dexamethasone treatment both in vitro and in vivo. This suggests that NFATc1 and NFATc2 are central to driving GC resistance, as they directly regulate crucial pathways like cholesterol biosynthesis and WNT/Î²-catenin signaling. The identification of NFAT transcription factors as key players in leukemia therapy resistance offers a promising target for future therapeutic strategies, potentially transforming the way we approach treatment for these challenging conditions or autoimmune disorders where glucocorticoids are a cornerstone of treatment.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253998" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE253996 ç ”ç©¶å‘ç°ï¼ŒNFATc1 å’Œ NFATc2 é€šè¿‡è°ƒèŠ‚èƒ†å›ºé†‡ç”Ÿç‰©åˆæˆå’Œ WNT/Î²-catenin é€šè·¯æ¥è°ƒæ§å„¿ç«¥ T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„ç³–çš®è´¨æ¿€ç´ æŠµæŠ—ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€resistanceã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Silvia Bresolin ; Valentina SerafinSeries Type : Expression profiling by arrayOrganism : Homo sapiensThe glucocorticoid (GC) resistance onset in pediatric T-cell Acute Lymphoblastic Leukemia (T-ALL) patients remains one of the biggest challenges in current cancer treatment. The mechanisms driving this resistance are still not fully understood, making it difficult to predict patient outcomes and to develop effective therapies. Our study uncovered critical insights into the biological processes underlying GC resistance, offering potential breakthroughs for future treatments. Building on our previous research on LCK kinase hyperactivation in GC-resistant T-ALL patients, we have now delved deeper into the LCK downstream NFAT transcription factor family's contribution to GC resistance. We discovered that, even at the time of diagnosis, GC resistant T-ALL patients exhibit an intrinsic low glucocorticoid receptor (GR) activity coupled with high NFATc1 and NFATc2 ones. This dysregulation creates a roadblock to effective GC therapy. Indeed, in the absence of either NFATc1 or NFATc2, the normal transcriptional activity of GR is restored, re-sensitizing the leukemia cells to dexamethasone treatment both in vitro and in vivo. This suggests that NFATc1 and NFATc2 are central to driving GC resistance, as they directly regulate crucial pathways like cholesterol biosynthesis and WNT/Î²-catenin signaling. The identification of NFAT transcription factors as key players in leukemia therapy resistance offers a promising target for future therapeutic strategies, potentially transforming the way we approach treatment for these challenging conditions or autoimmune disorders where glucocorticoids are a cornerstone of treatment.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253996" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE287189ï¼šå¹´è½»å’Œå¹´è€å¡è±é»‘ç¾Šåµå·¢ä¸­m6Aç”²åŸºåŒ–å’Œè½¬å½•ç»„è°±å·®å¼‚çš„ç»¼åˆåˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štranscriptomeã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Linlin Pei ; Chunjie LiuSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Ovis ariesOvarian aging results in follicular failure and atresia, leading to a decline in both the quantity and quality of oocytes. N6-methyladenosine (m6A) has been demonstrated to play a regulatory role in the reproductive functions of female animals; however, the regulatory mechanisms of m6A in the ovaries of sheep remain unclear. In the present study, ovarian tissues from 1~2 year-old and 5~6 year-old Cele black sheep were collected and analyzed using MeRIP-seq and RNA-seq sequencing. A total of 109 differentially methylated genes were identified, including 7 genes that were up-regulated in both methylation and mRNA expression, 55 genes that were up-regulated in methylation while down-regulated in mRNA expression, and 33 genes that were down-regulated in both methylation and mRNA expression. Additionally, 14 genes exhibited down-regulation in methylation and up-regulation in mRNA expression. Differential methylation peaks (DMPs) were found to be significantly enriched in the BMP signaling pathway, uterine embryonic development, histone acetyltransferase activity, and VEGF signaling pathway by GO and KEGG enrichment analysis. Differentially expressed genes (DEGs) were significantly enriched in negative regulation of the I-kappaB kinase/NF-kappaB signalling pathway, positive regulation of leukocyte adhesion to vascular endothelial cells, histone methyltransferase binding, transcriptional co-repressor activity, and cellular senescence. The results suggest that differentially expressed genes may influence various biological functions, including transcription, translation, aging, development, regeneration, and immune responses in the ovary of sheep. In this study, we constructed the first comprehensive whole transcriptome analysis map of the sheep ovary, which provides a theoretical foundation for investigating the transcriptional regulation mechanisms of m6A modification in the ovary.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287189" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE272644 BRCA1 çªå˜å’Œè¡¨è§‚çªå˜æºå¸¦è€…çš„è¡€ç»†èƒå…¨åŸºå› ç»„ç”²åŸºåŒ–è°±ã€ä¹³è…ºç™Œè¯Šæ–­å‰æ—¢æ—  BRCA1 çªå˜ä¹Ÿæ— è¡¨è§‚çªå˜çš„å¥³æ€§ä»¥åŠæ—¢æ—  BRCA1 çªå˜ä¹Ÿæ— è¡¨è§‚çªå˜çš„å¥åº·å¥³æ€§ï¼ˆå¯¹ç…§ç»„ï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgenomeã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Katarzyna E Sokolowska ; Jacek Antoniewski ; Marta Sobalska-Kwapis ; Dominik Strapagiel ; Jan LubiÅ„ski ; Tomasz Huzarski ; Tomasz K WojdaczSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensGenome-wide DNA methylation patterns were quantified in peripheral blood samples collected from 112 individuals (with determined BRCA1 mutation and epimutation status) using the Illumina Infinium HumanMethylationEPIC BeadChip<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272644" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE272599 ä½¿ç”¨TIGERå¯¹Recql4 -/- Klhdc3 -/- ä¸å¯¹ç…§ç»„è¿›è¡Œå…¨åŸºå› ç»„æµ‹åºï¼ˆä¸‰é‡å¤ï¼‰ï¼Œåˆ†æå…¶å¤åˆ¶æ—¶é—´ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€genome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : M F Smeets ; P A Buco ; A Koren ; A M Chalk ; C R WalkleySeries Type : OtherOrganism : Mus musculusAbstract TBC<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272599" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 34 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>æ™šæœŸå®«é¢ˆç™Œä¸­ï¼Œä¸€çº¿é™çº§åŒ–ç–—åŠ å½­æ™®åˆ©å•æŠ—å’Œå®‰æ´›æ›¿å°¼ååº”çš„åˆ†å­å’Œå…ç–«ç›¸å…³æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æ™šæœŸå®«é¢ˆç™Œçš„æ ‡å‡†æŠ¤ç†åŒ…æ‹¬åŒ–ç–—ã€æŠ—è¡€ç®¡ç”Ÿæˆå’Œ/æˆ–å…ç–«æ£€æŸ¥ç‚¹é˜»æ»æ–¹æ¡ˆã€‚è™½ç„¶æœ‰æ•ˆï¼Œä½†ä¼šå¯¼è‡´å¤šæ•ˆæ€§å‰¯ä½œç”¨ã€‚é™çº§åŒ–ç–—ç»“åˆå…ç–«é¶å‘ç–—æ³•å·²è¢«è¯æ˜åœ¨å…¶ä»–ç™Œç—‡ä¸­æœ‰æ•ˆä¸”æ¯’æ€§è¾ƒä½ã€‚æœ¬ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬è¿›è¡Œäº†ä¸€é¡¹å¤šä¸­å¿ƒã€å•è‡‚ã€äºŒæœŸä¸´åºŠç ”ç©¶ï¼Œé’ˆå¯¹ä¸€çº¿é™çº§é“‚ç±»åŒ–ç–—åŠ å®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—ï¼Œéšåä»…ç”¨å®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—ç»´æŒæ²»ç–—æ²»ç–—ï¼Œæ²»ç–— PD-L1 é˜³æ€§ã€æŒç»­æ€§ã€å¤å‘æˆ–è½¬ç§»æ€§å®«é¢ˆç™Œæ‚£è€…ã€‚åœ¨ 32 ä¾‹æœ‰æ•ˆæ€§è¯„ä¼°æ‚£è€…ä¸­ï¼Œ30 ä¾‹ï¼ˆ93.8%ï¼Œ95%ç½®ä¿¡åŒºé—´ï¼š79.2%è‡³ 99.2%ï¼‰è·å¾—ç ”ç©¶è€…ç¡®è®¤çš„å®¢è§‚ååº”ã€‚å•æ ¸ RNA æµ‹åºæš—ç¤ºè‚¿ç˜¤æµ¸æ¶¦ T ç»†èƒå’Œæ´»åŒ–ç”Ÿæ®–ä¸­å¿ƒ B ç»†èƒçš„è¶‹åŒ–æ€§å’Œå¢æ®–æ´»æ€§å¢å¼ºï¼Œé¢„ç¤ºç€æœ€ä½³æ²»ç–—ååº”ã€‚TLS ä¸è‚¿ç˜¤é¢ç§¯æ¯”è¾ƒé«˜çš„æ‚£è€…å­˜æ´»ç‡è¾ƒé«˜ã€‚æˆ‘ä»¬çš„å‘ç°ä¸ºä¸€çº¿é™çº§åŒ–ç–—åŠ å®‰æ´›æ›¿å°¼å’Œå½­æ™®åˆ©å•æŠ—åœ¨è½¬ç§»æ€§ã€æŒç»­æ€§æˆ–å¤å‘æ€§å®«é¢ˆç™Œæ‚£è€…ä¸­çš„å¯è¡Œæ€§å¥ å®šäº†åŸºç¡€ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1994144241297764352/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>å¯¹ CICï¼š:D UX4 è‚‰ç˜¤çš„å»ºæ¨¡æ­ç¤ºäº†ç™ŒåŸºå› ä»‹å¯¼çš„ MHCI ä¾èµ–å…ç–«é€ƒè„±ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: CICï¼š:D UX4 è‚‰ç˜¤ï¼ˆCDSï¼‰æ˜¯ä¸€ç§é«˜åº¦ä¾µè¢­æ€§çš„æ¶æ€§è‚¿ç˜¤ï¼Œæ²»ç–—é€‰æ‹©æœ‰é™ã€‚æœ¬æ–‡ä»‹ç»äº†ä¸€ä¸ªå¯è¯±å¯¼å¤šè¥¿ç¯ç´ çš„ CICï¼š:D UX4 åµŒåˆå°é¼ æ¨¡å‹åŠå…¶è¡ç”Ÿçš„ç™Œç—‡ç³» imChCDSï¼Œå¿ å®åœ°é‡ç°äº†äººç±» CDS çš„åˆ†å­ã€ç»„ç»‡å­¦å’Œå…ç–«å­¦ç‰¹å¾ã€‚æˆ‘ä»¬è¯æ˜ä»… CICï¼š:D UX4 è¡¨è¾¾å°±è¶³ä»¥é©±åŠ¨è½¯ç»“ç¼”ç»„ç»‡å…è®¸è°±ç³»çš„è‚¿ç˜¤å‘ç”Ÿã€‚imChCDS ç»†èƒç³»ä¿ç•™äº†å…¶é—´å……è´¨ç»†èƒèµ·æºçš„è½¬å½•è¶³è¿¹ï¼Œåœ¨å…ç–«åŠŸèƒ½æ­£å¸¸çš„å®¿ä¸»ä¸­å‘ç”Ÿè½¬ç§»æ€§è‚¿ç˜¤ï¼Œå¹¶æ˜æ˜¾ä¾èµ– P300/CBP è½¬å½•å…±æ¿€æ´»å› å­ã€‚å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œæˆ‘ä»¬å‘ç° CICï¼š:D UX4/P300/CBP ä»‹å¯¼çš„ MHC I ç±»ï¼ˆMHCIï¼‰æŠ‘åˆ¶æ˜¯ CDS å…ç–«é€ƒé¿çš„å…³é”®æœºåˆ¶ã€‚CICï¼š:D UX4 çš„é—ä¼ å¤±æ´»æˆ– P300/CBP çš„è¯ç‰©æŠ‘åˆ¶å¯è¯±å¯¼ç™Œç»†èƒå‘¨æœŸåœæ­¢ï¼Œæ¢å¤ MHCI è¡¨è¾¾ï¼Œå¹¶è§¦å‘å¼ºå¥çš„æŠ—è‚¿ç˜¤å…ç–«ååº”ï¼Œä»è€Œå°†å…ç–«å­¦ä¸Šâ€œå†·â€çš„ CDS å¾®ç¯å¢ƒè½¬å˜ä¸ºâ€œçƒ­â€ç¯å¢ƒï¼Œæ¨åŠ¨è‚¿ç˜¤é€€ç¼©ã€‚è¿™äº›æ¨¡å‹å…±<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1994175845021888512/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¸€é¡¹å†æ—¶äºŒåå¹´çš„ç ”ç©¶è¡¨æ˜ï¼Œæ›´æ¸…æ´çš„æ°´èƒ½å¤§å¹…é™ä½ç™Œç—‡å’Œå¿ƒè„ç—…æ­»äº¡ç‡ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA 20-year project in Bangladesh reveals that lowering arsenic levels in drinking water can slash death rates from major chronic diseases. Participants who switched to safer wells had the same risk levels as people who were never heavily exposed. The researchers tracked individual water exposure with detailed urine testing. Their results show how quickly health improves once contaminated water is replaced.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251127010327.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>ä½ çš„èº«ä½“å¯èƒ½å·²ç»å­˜åœ¨ä¸€ç§æœ‰åŠ©äºå¯¹æŠ—é˜¿å°”èŒ¨æµ·é»˜ç—…çš„åˆ†å­ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSpermine, a small but powerful molecule in the body, helps neutralize harmful protein accumulations linked to Alzheimerâ€™s and Parkinsonâ€™s. It encourages these misfolded proteins to gather into manageable clumps that cells can more efficiently dispose of through autophagy. Experiments in nematodes show that spermine also enhances longevity and cellular energy production. These insights open the door to targeted therapies powered by polyamines and advanced AI-driven molecular design.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251126095023.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>çº³ç±³èŠ±å¢å¼ºå¹²ç»†èƒæ´»åŠ›ï¼Œä»è€Œä¿®å¤è¡°è€ç»†èƒ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šaging<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šTexas A&amp;M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower particles. These energized stem cells then transfer their surplus â€œpower packsâ€ to weakened cells, reviving their energy production and resilience. The method bypasses many limitations of current mitochondrial therapies and could offer long-lasting effects. It may open the door to treatments for aging tissues and multiple degenerative diseases.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251126095020.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>è¿™ç§å¾®å°çš„å¾®ç”Ÿç‰©æˆ–è®¸æ˜¯æˆ˜èƒœæ°¸ä¹…æ€§åŒ–å­¦ç‰©è´¨çš„å…³é”®ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:micro(b|be|bial|organism)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA photosynthetic bacterium shows a surprising ability to absorb persistent PFAS chemicals, offering a glimpse into biological tools that might one day tackle toxic contamination. Researchers are now exploring genetic and synthetic biology approaches to enhance these early signs of PFAS-handling potential.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251125081938.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>å…ç–«</td>
<td>10</td>
</tr>
<tr>
<td>ç”Ÿä¿¡</td>
<td>9</td>
</tr>
<tr>
<td>è‚¿ç˜¤</td>
<td>7</td>
</tr>
<tr>
<td>å•ç»†èƒ</td>
<td>7</td>
</tr>
<tr>
<td>Tç»†èƒ</td>
<td>7</td>
</tr>
<tr>
<td>epigenetic</td>
<td>7</td>
</tr>
<tr>
<td>ä»£è°¢</td>
<td>5</td>
</tr>
<tr>
<td>genome</td>
<td>5</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>5</td>
</tr>
<tr>
<td>immune</td>
<td>5</td>
</tr>
<tr>
<td>resistance</td>
<td>5</td>
</tr>
<tr>
<td>cancer</td>
<td>5</td>
</tr>
<tr>
<td>æµ‹åº</td>
<td>4</td>
</tr>
<tr>
<td>è¡°è€</td>
<td>4</td>
</tr>
<tr>
<td>è€è¯</td>
<td>4</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>4</td>
</tr>
<tr>
<td>leukemia</td>
<td>4</td>
</tr>
<tr>
<td>pathway</td>
<td>4</td>
</tr>
<tr>
<td>å·¨å™¬ç»†èƒ</td>
<td>3</td>
</tr>
<tr>
<td>sequencing</td>
<td>3</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (28æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503148&amp;idx=2&amp;sn=1fd522a4f521da4c2d9cc0939cfcc9d2" target="_blank" rel="noopener noreferrer">è‚¿ç˜¤å…ç–« | TrendsCancer | è›‹ç™½é…¶å¯¹è‚¿ç˜¤-å…ç–«ç»†èƒå…±ç”Ÿå…³ç³»çš„è°ƒæ§</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503148&amp;idx=1&amp;sn=be44ba4e48cf8e1bf1560c82e222b946" target="_blank" rel="noopener noreferrer">åŸºå› ç»„ | Nature | é€šè¿‡ä½“ç»†èƒè¡¨çªå˜çš„å…‹éš†è¿½è¸ªæ­ç¤ºè¡€æ¶²è¡°è€çš„åŠ¨æ€å˜åŒ–</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493048&amp;idx=1&amp;sn=23ee503b89c7c9e5d07510a46b3cda5a" target="_blank" rel="noopener noreferrer">æœ€æ–°Cancer Cellé‡ç£…ï¼Œèƒ°è…ºç™Œä¸­é¦–æ¬¡è¯å®ç¥ç»å…ƒä¸ç™Œç»†èƒé—´å­˜åœ¨ â€œç¥ç»å…ƒ-ç™Œç»†èƒå‡æ€§çªè§¦â€ï¼Œå¹¶å½¢æˆæ­£åé¦ˆå¢å¼ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247538298&amp;idx=1&amp;sn=59bd299693570cbcb39fd84948671b12" target="_blank" rel="noopener noreferrer">PDXå°é¼ DNAæµ‹åºæ¯”å¯¹åˆ°äººç±»æˆ–è€…å°é¼ å‚è€ƒåŸºå› ç»„ï¼ˆä½ ä»¥ä¸ºçš„æ¯”å¯¹å¹¶ä¸æ˜¯çœŸæ­£çš„æ¯”å¯¹ï¼‰</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI4ODc5MDI5NA==&amp;mid=2247503612&amp;idx=1&amp;sn=7cefeafa15508d5f783ef97effbe6a3c" target="_blank" rel="noopener noreferrer">ã€Šè‡ªç„¶ã€‹ï¼šæ•™ç§‘ä¹¦åˆå¾—æ”¹äº†ï¼ç§‘å­¦å®¶é¦–æ¬¡å‘ç°ï¼ŒæŠ‘åˆ¶Tç»†èƒæŠ—ç™Œæ´»æ€§çš„PD-1ï¼Œç«Ÿç„¶è¿˜æ˜¯Tç»†èƒçš„ä¿æŠ¤ä¼ï¼Œå¯ä»¥é˜²æ­¢æ·‹å·´ç»“å†…Tç»†èƒè€—ç«­æˆ–æ­»äº¡</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507736&amp;idx=1&amp;sn=df2b3e3cf7abe1c367c6ebfe671dc1a5" target="_blank" rel="noopener noreferrer">Cell Res | æ—åœ£å½©ç­‰å›¢é˜Ÿå‘ç°é€šè¿‡ä»£è°¢è°ƒæ§æ¥è°ƒåŠ¨ä½“å†…å›ºæœ‰å…ç–«åŠ›ï¼Œä½¿è‚ç™Œå°é¼ å®ç°å¯¿ç»ˆæ­£å¯â€”â€”â€œä»£è°¢æ€§å…ç–«æ²»ç–—â€</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=1&amp;sn=cd297931054a03df2da9e86bee1aee2e" target="_blank" rel="noopener noreferrer">Scienceç ´é¢˜ï¼šè¿™ä¸€åˆ†å­å†³å®šè‚¿ç˜¤å…ç–«èƒ½å¦çœŸæ­£è¢«æ¿€æ´»</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247659599&amp;idx=1&amp;sn=ed4923d85bb6214c8b5378f34d9d68d6" target="_blank" rel="noopener noreferrer">æˆ´ç£Šå›¢é˜ŸCHOMï¼šåŸºäºè›‹ç™½ç»“æ„æ£€ç´¢çš„äººä½“è‚ é“å¾®ç”Ÿç‰©ç»„åŠŸèƒ½ç ”ç©¶æ–°èŒƒå¼ | Cell Presså¯¹è¯ç§‘å­¦å®¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821476&amp;idx=2&amp;sn=a7390fff7939786b75f4bb83dc6b429e" target="_blank" rel="noopener noreferrer">å½“å¯¼å¸ˆåªç»™æˆ‘ä¸€ä¸ªå•ç»†èƒæµ‹åºæ•°æ®ï¼Œæˆ‘æ˜¯æ€ä¹ˆè®¾è®¡4ä¸ªè¯¾é¢˜çš„1â€”â€”å¦‚ä½•æŒ‘é€‰ç»†èƒç¾¤</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247534012&amp;idx=1&amp;sn=3234de029a12bd2eac1c4a275b5938a3" target="_blank" rel="noopener noreferrer">è¯è¿›ä¸ƒ | ä»å°ç”¨Windowsï¼Œç»ˆäºå¼€å§‹åšç”Ÿä¿¡</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484121&amp;idx=1&amp;sn=cada5367af04b24fdd5c40c77caaeb9e" target="_blank" rel="noopener noreferrer">ä¹™é†‡é…¸ä»£è°¢é€”å¾„ï¼ˆå»ºè®®æ”¶è—ï¼‰</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498522&amp;idx=1&amp;sn=b10488729a588f8e6f7a535533277b31" target="_blank" rel="noopener noreferrer">è¿˜åœ¨è‹¦è‹¦æ¯”å¯¹å¾®ç”Ÿç‰©åºåˆ—ï¼ŸKraken2è½»æ¾å®ç°è¶…å¿«é€Ÿçš„å¾®ç”Ÿç‰©ç»„åˆ†ç±»ï¼Œæ•°æ®å¤„ç†æ•ˆç‡ç¿»å€ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=6&amp;sn=f4c9c7c27a1f866556e5882bff5487d9" target="_blank" rel="noopener noreferrer">å‘è¡¨åœ¨14.3åˆ†1åŒºï¼ˆAdvanced Scienceï¼‰çš„å¹²æ¹¿ç»“åˆæ–‡ç« ï¼Œèšç„¦åœ¨æˆçº¤ç»´ç»†èƒçš„è¡°è€è¡¨å‹ï¼Œå€¼å¾—å­¦ä¹ æ”¶è—ï¼Œå¯é‡å¤ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247504099&amp;idx=3&amp;sn=4051b2330fdacd9461926cc7fb936397" target="_blank" rel="noopener noreferrer">åˆšåˆšå‘è¡¨çš„14+ç”Ÿä¿¡åˆ†æï¼Œè¯†åˆ«MMP11+æˆçº¤ç»´ç»†èƒè¿›è¡Œåˆ†æå’ŒéªŒè¯ï¼Œæœ¬æ–‡æ€è·¯æ–°é¢–ï¼Œå€¼å¾—è®¤çœŸå­¦ä¹ æ¨¡ä»¿ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247569258&amp;idx=2&amp;sn=2ba1887999f9f5d8eb07846d8317268f" target="_blank" rel="noopener noreferrer">ä»â€œæ— è¯å¯æ²»â€åˆ°â€œæœ‰è¯å¯åŒ»â€åŠæ•°åæ¬¾æ–°è¯åœ¨ç ”ï¼Œè¿™ç±»ç™Œç—‡æ‚£è€…è¿æ–°æ›™å…‰ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247569258&amp;idx=1&amp;sn=5a38565b32a19ac9aefbbec594226640" target="_blank" rel="noopener noreferrer">ã€Šè‡ªç„¶ã€‹é‡ç£…ï¼šç ´è§£ç»“ç›´è‚ ç™Œè€è¯ä¹‹è°œï¼æ–°ä¸€ä»£æ²»ç–—æ–¹å‘å·²å‡ºç°</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247547242&amp;idx=1&amp;sn=998166214fd574f2e22a9fda394de620" target="_blank" rel="noopener noreferrer">scATAC-seqåˆ†æï¼šå¦‚ä½•ä½¿ç”¨ bam åˆ›å»ºArrowæ–‡ä»¶ï¼Ÿ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MTExNTkwNA==&amp;mid=2247573862&amp;idx=1&amp;sn=2b98e046fb777713fcaa65a2a39fafd7" target="_blank" rel="noopener noreferrer">ç«‹æ„é«˜è¿œï¼è¿™ç¯‡Nature Canceræªå‡ºäº†è‚ç™Œç™Œå‰ç»†èƒçš„å…³é”®é¶ç‚¹ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=7&amp;sn=043be78cbaf4346fee0bd188add122f4" target="_blank" rel="noopener noreferrer">67åˆ†å·¨ä½œï¼Œå¸¦ä½ ç”¨çˆ†ç«çš„ä»£è°¢é‡ç¼–ç¨‹å®ç°å¼¯é“è¶…è½¦</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=6&amp;sn=aa07cacc08c353b5a8129e7ac883519e" target="_blank" rel="noopener noreferrer">Cell Genomæœ€æ–°åŠ›ä½œï¼å¤šç»„å­¦+å­Ÿå¾·å°”éšæœºåŒ–åˆ†æï¼Œç ´è§£è¡€æ¸…ä»£è°¢ç‰©ä¸æ…¢æ€§ç–¾ç—…çš„é—ä¼ å…³è”ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=5&amp;sn=41622cb46ce43273bad0096b7c36c932" target="_blank" rel="noopener noreferrer">28 æ ·æœ¬ IF40.4ï¼è§£å¯†ç‹çº¢é˜³é™¢å£«å›¢é˜Ÿçš„å•ç»†èƒåˆ›æ–°å¯†ç </a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=3&amp;sn=c23aa42c89c94b35f9a21d3338eed481" target="_blank" rel="noopener noreferrer">æœ€æ–°27+ç”Ÿä¿¡ï¼ŒåŸæ¥åªåšäº†è¿™äº›æ“ä½œï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248980&amp;idx=2&amp;sn=88531863743ccd2990dbb14426750f92" target="_blank" rel="noopener noreferrer">é¢„åˆ¶èœæœ€åº”è¯¥å‡ºç°åœ¨ç”Ÿä¿¡é¢†åŸŸ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247650903&amp;idx=5&amp;sn=e9d1ca081df717f5c0acb5f04c4be751" target="_blank" rel="noopener noreferrer">PNASï¼šä¸­å±±å¤§å­¦ç‹å†›èˆ°å›¢é˜Ÿåœ¨å°ç»†èƒè‚ºç™ŒåŒ–ç–—è€è¯æ–°æœºåˆ¶åŠå¹²é¢„æ–°é¶ç‚¹ç ”ç©¶é¢†åŸŸå–å¾—è¿›å±•</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247650903&amp;idx=1&amp;sn=ffa679be1223d7152ce8074c16138087" target="_blank" rel="noopener noreferrer">è¿™ç§å¸¸è§ç»´ç”Ÿç´ ï¼Œç«Ÿæ˜¯æŠ—è‚¿ç˜¤é¶ç‚¹ï¼æ¸…åå¤§å­¦å›¢é˜Ÿå‘ç°ï¼šé€šè¿‡è†³é£Ÿè·å–å³å¯ä¿ƒè¿›è‚¿ç˜¤æ¸…é™¤èƒ½åŠ›</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495770&amp;idx=1&amp;sn=95c60c376c5d08a7ee6f4b7b4a2906fd" target="_blank" rel="noopener noreferrer">Natureå­åˆŠ |æ™ºèƒ½ç©ºé—´ç»„å­¦æŠ€æœ¯ S2-omic |è¯»è¿™ç¯‡æ–‡ç« èƒ½æŠŠç©ºé—´ç»„å­¦ç°çŠ¶ã€åº”ç”¨å’Œæ•°æ®åˆ†æå­¦æ˜ç™½</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656511096&amp;idx=4&amp;sn=4433f4b8ae80caa09264fc6b5753cd49" target="_blank" rel="noopener noreferrer">å¯é¢„æµ‹ICI-åŒ–ç–—æ²»ç–—æ•ˆæœï¼ä¸­å›½åŒ»å­¦ç§‘å­¦é™¢è‚¿ç˜¤åŒ»é™¢ç­‰å•ä½å‘æ–‡ï¼šæœ‰å‰æ™¯çš„è‚ºç™Œé¢„æµ‹ç”Ÿç‰©æ ‡å¿—ç‰©</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247490144&amp;idx=1&amp;sn=3418f002325fbfcf782ec096c24dcb34" target="_blank" rel="noopener noreferrer">é«˜æµ“åº¦å±€éƒ¨è¾£æ¤’ç´ æ²»ç–—ç³–å°¿ç—…å‘¨å›´ç¥ç»ç—…å˜:æœºåˆ¶ä¸ä¸´åºŠå‰æ™¯</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (34æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306804" target="_blank" rel="noopener noreferrer">GSE306804 äº§åæ¯ä½“è¡€æ¶²ä¸­ç»†èŒçš„å¿«é€Ÿæ¸…é™¤ï¼Œé€‚ç”¨äºèƒè†œæ—©ç ´å¹¶å‘å¦Šå¨ çš„æƒ…å†µã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311151" target="_blank" rel="noopener noreferrer">GSE311151 è„‘ç™Œæ‚£è€…ä½“å†…ä»£è°¢é€šé‡ä¼°ç®—çš„æ•°å­—å­ªç”Ÿæ¨¡å‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310554" target="_blank" rel="noopener noreferrer">GSE310554 é…å¯¹è¡€ç®¡-å®è´¨å•æ ¸æµ‹åºæ­ç¤ºé˜¿å°”èŒ¨æµ·é»˜ç—…ä¸­å†…çš®-é—´è´¨è½¬åŒ–ç´Šä¹±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298006" target="_blank" rel="noopener noreferrer">GSE298006 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨åœ¨è°±ç³»å†³å®šè¿‡ç¨‹ä¸­å¢å¼ºåŸºå› æ¿€æ´» [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298001" target="_blank" rel="noopener noreferrer">GSE298001 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨åœ¨è°±ç³»å†³å®šè¿‡ç¨‹ä¸­å¢å¼ºåŸºå› æ¿€æ´» [ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295550" target="_blank" rel="noopener noreferrer">GSE295550 æŸ“è‰²è´¨å¯åŠæ€§å’ŒåŸºå› è¡¨è¾¾åŠ¨æ€è¡¨æ˜ç»´ç”Ÿç´  D3 åœ¨ä½“å†…å…·æœ‰å…ç–«è°ƒèŠ‚ä½œç”¨ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295549" target="_blank" rel="noopener noreferrer">GSE295549 æŸ“è‰²è´¨å¯åŠæ€§å’ŒåŸºå› è¡¨è¾¾åŠ¨æ€æ­ç¤ºç»´ç”Ÿç´  D3 åœ¨ä½“å†…çš„å…ç–«è°ƒèŠ‚ä½œç”¨ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286942" target="_blank" rel="noopener noreferrer">GSE286942 DOT1LæŠ‘åˆ¶å‰‚é€šè¿‡æ¿€æ´»ä¹³è…ºç™Œç»†èƒä¸­çš„å¹²æ‰°ç´ ä¿¡å·é€šè·¯å‘æŒ¥æŠ—è‚¿ç˜¤ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235046" target="_blank" rel="noopener noreferrer">GSE235046 å…ˆå¤©å…ç–«å’Œä»£è°¢ä¿¡å·å°†å—æŸçº¿ç²’ä½“æ»ç•™åœ¨ç»†èƒè†œä¸Šä»¥è¿›è¡Œçº¿ç²’ä½“æ°§åŒ–æŸä¼¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221564" target="_blank" rel="noopener noreferrer">GSE221564 è‚¿ç˜¤ç»†èƒå†…åœ¨RIG-Iæ¿€æ´»è¶³ä»¥é©±åŠ¨å…ç–«ä»‹å¯¼çš„è‚¿ç˜¤æ’æ–¥</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302831" target="_blank" rel="noopener noreferrer">GSE302831 é€šè¿‡RNAæµ‹åºé‰´å®šé“¶å±‘ç—…ä¸­å·®å¼‚è¡¨è¾¾åŸºå› </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292493" target="_blank" rel="noopener noreferrer">GSE292493 C-Cè¶‹åŒ–å› å­å—ä½“4çš„åŸºå› ç¼ºé™·å¯ä¿æŠ¤å°é¼ å…å—è¡€ç®¡ç´§å¼ ç´ IIè¯±å¯¼çš„è…¹ä¸»åŠ¨è„‰ç˜¤å½¢æˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291310" target="_blank" rel="noopener noreferrer">GSE291310 L-è‹¯ä¸™æ°¨é…¸å¯¹Th2ç»†èƒçš„ä»£è°¢è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288012" target="_blank" rel="noopener noreferrer">GSE288012 å…¨åŸºå› ç»„ç­›é€‰é‰´å®šå‡º Runx2 æ˜¯é€ è¡€å¹²ç»†èƒæ‰©å¢å’Œ T ç»†èƒåˆ†åŒ–çš„æ–°å‹è°ƒæ§å› å­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285478" target="_blank" rel="noopener noreferrer">GSE285478 å¤–æ³Œä½“ CLOCK ç¨³å®š lncRNA èµ‹äºˆç»“æ ¸ç—…æŠµæŠ—è€…å…ˆå¤©è®°å¿† [RNAseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281009" target="_blank" rel="noopener noreferrer">GSE281009 é—´å……è´¨IL-33æ¿€æ´»ä¿®å¤æ€§å·¨å™¬ç»†èƒï¼Œä¿ƒè¿›è¡€ç®¡å†…æŸä¼¤è¯±å¯¼çš„æ–°å†…è†œå¢ç”Ÿ[scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281008" target="_blank" rel="noopener noreferrer">GSE281008 é—´å……è´¨IL-33æ¿€æ´»ä¿®å¤æ€§å·¨å™¬ç»†èƒï¼Œä¿ƒè¿›è¡€ç®¡å†…æŸä¼¤è¯±å¯¼çš„æ–°å†…è†œå¢ç”Ÿ[RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273174" target="_blank" rel="noopener noreferrer">GSE273174 åœ¨å…¨åŸºå› ç»„ CRISPR/Cas9 æ‹¯æ•‘ç­›é€‰ä¸­é‰´å®šä¸ Recql4 çš„æ–°å‹åŸºå› ç›¸äº’ä½œç”¨ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273006" target="_blank" rel="noopener noreferrer">GSE273006 åœ¨å…¨åŸºå› ç»„ CRISPR/Cas9 åˆæˆè‡´æ­»ç­›é€‰ä¸­é‰´å®šä¸ Recql4 çš„æ–°å‹åŸºå› ç›¸äº’ä½œç”¨ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311318" target="_blank" rel="noopener noreferrer">GSE311318 è½¯éª¨å¯¡èšåŸºè´¨è›‹ç™½ï¼ˆCOMPï¼‰åŸºå› ä¸é«˜çº§åˆ«è†€èƒ±ç™Œç›¸å…³å¹¶ä¿ƒè¿›è†€èƒ±ç™Œç»†èƒå¢æ®–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311202" target="_blank" rel="noopener noreferrer">GSE311202 å¤§è‚ æ†èŒæ„ŸæŸ“æœŸé—´ä¸ Th17 ç»†èƒå…±åŸ¹å…»çš„å£è…”è§’è´¨å½¢æˆç»†èƒçš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310377" target="_blank" rel="noopener noreferrer">GSE310377 èƒç›˜å¤–æ³Œä½“ miR-24-1-5p åœ¨ LPS è¯±å¯¼çš„ç‚ç—‡ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307410" target="_blank" rel="noopener noreferrer">GSE307410 è«å“ˆç»´èŠ½å­¢æ†èŒåç”Ÿå…ƒï¼šå¯¹ç»“è‚ ç™Œç»†èƒçš„è½¬å½•ç»„å­¦å’ŒæŠ—ç™Œä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298010" target="_blank" rel="noopener noreferrer">GSE298010 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [Micro-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298008" target="_blank" rel="noopener noreferrer">GSE298008 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [å¤šç»„]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298005" target="_blank" rel="noopener noreferrer">GSE298005 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [RELACS]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298002" target="_blank" rel="noopener noreferrer">GSE298002 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨å¢å¼ºè°±ç³»å®šå‘è¿‡ç¨‹ä¸­çš„åŸºå› æ¿€æ´» [CUT&amp;Run]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298000" target="_blank" rel="noopener noreferrer">GSE298000 é˜¶æ®µç‰¹å¼‚æ€§è¡¨è§‚é—ä¼ å¯åŠ¨åœ¨è°±ç³»å†³å®šè¿‡ç¨‹ä¸­å¢å¼ºåŸºå› æ¿€æ´» [4C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291575" target="_blank" rel="noopener noreferrer">GSE291575 ä½“å¤–å¾ªç¯é€šè¿‡å‰ªåˆ‡åŠ›ä»‹å¯¼çš„é’™åº“æ“çºµæ€§å†…æµæ¿€æ´»ç»å…¸å•æ ¸ç»†èƒ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279595" target="_blank" rel="noopener noreferrer">GSE279595 A-to-I RNA ç¼–è¾‘å¯é¢„é˜²è„‚è‚ªç»„ç»‡ä¸­ç‚ç—‡ä»‹å¯¼çš„è„‚è‚ªè¥å…»ä¸è‰¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221529" target="_blank" rel="noopener noreferrer">GSE221529 ç–¾ç—…ç›¸å…³çš„ p63 DBD çªå˜é€šè¿‡ä¸åŒçš„æœºåˆ¶å’Œä¸åŒç¨‹åº¦æŸå®³ DNA ç»“åˆ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221525" target="_blank" rel="noopener noreferrer">GSE221525 ç–¾ç—…ç›¸å…³çš„ p63 DBD çªå˜é€šè¿‡ä¸åŒçš„æœºåˆ¶å’Œä¸åŒç¨‹åº¦æŸå®³ DNA ç»“åˆ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221520" target="_blank" rel="noopener noreferrer">GSE221520 ç–¾ç—…ç›¸å…³çš„ p63 DBD çªå˜é€šè¿‡ä¸åŒçš„æœºåˆ¶å’Œä¸åŒç¨‹åº¦æŸå®³ DNA ç»“åˆ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221088" target="_blank" rel="noopener noreferrer">GSE221088 åŸºäºå¾ªç¯å°ç»†èƒå¤–å›Šæ³¡çš„ miRNA åˆ†ç±»å™¨åœ¨æ»¤æ³¡æ€§ç”²çŠ¶è…ºç™Œè¯Šæ–­ä¸­çš„åº”ç”¨ï¼šä¸€é¡¹å¤šä¸­å¿ƒè¯Šæ–­ç ”ç©¶</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-28 21:33</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>